Search results
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 10 hours agoFurthermore, it would be beneficial for investors to monitor any recent shifts in analyst...
Eli Lilly and Company (NYSE:LLY) Shares Sold by Knights of Columbus Asset Advisors LLC
ETF DAILY NEWS· 1 day agoEli Lilly and Company (NYSE:LLY – Free Report) by 25.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional ...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 5 days agoMeanwhile, sales from blockbuster insulins Humalog and Humulin are expected to fall now that Lilly...
Eli Lilly buys injectable medicine manufacturing facility in Wisconsin (NYSE:LLY)
Seeking Alpha· 17 hours agoEli Lilly acquires manufacturing facility from Nexus Pharmaceuticals, expanding its global...
Eli Lilly's Mounjaro, Zepbound to remain in shortage through end of Q2 (NYSE:LLY)
Seeking Alpha· 6 days agoEli Lilly's semaglutide-based drugs for diabetes and weight loss, Mounjaro and Zepbound, will face...
Eli Lilly Shares Show Healthy Rise
FX Empire via Yahoo Finance· 4 days agoEli Lilly and Company (LLY) shares are up in 2024 to the tune of 28% so far. Looking under the surface, it’s clear to see why this biopharmaceuticals ...
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
Motley Fool via Yahoo Finance· 5 days agoSome good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of...
Eli Lilly maintains stock price target with obesity treatment data By Investing.com
Investing.com· 6 days agoOn Wednesday, TD Cowen reaffirmed its Buy rating and $850.00 price target for Eli Lilly and Company (NYSE:LLY) shares. The endorsement ...
Promise of Eli Lilly's weight-loss drug for sleep apnea adds another reason to own the stock
CNBC· 5 days agoEli Lilly 's weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving...
Eli Lilly and Company (NYSE:LLY) Shares Down 0.1%
ETF DAILY NEWS· 3 days agoEli Lilly and Company (NYSE:LLY – Get Free Report)’s share price dropped 0.1% during trading on Thursday . The stock
